1. Consensus development conference on antipsychotic drugs and obesity and diabetes. American Diabetes Association; American Psychiatric Association; American Association of Clinical Endocrinologists; North American Association for the Study of Obesity;ADA/APA/AACE/NAASO;Diabetes Care,2004
2. The distribution of body mass index among individuals with and without schizophrenia;Allison;J. Clin. Psychiatry,1999
3. Development of an atherogenic metabolic risk factor profile associated with the use of atypical antipsychotics;Almeras;J. Clin. Psychiatry,2004
4. Cost-effectiveness analysis of pharmacological treatments in schizophrenia: critical review of results and methodological issues;Basu;Schizophr. Res.,2004
5. Blonde, L., Ray, S., Carson, W., L'Italien, G., 2005. Metabolic syndrome is an important predictor of cardiovascular disease and new onset diabetes. A systematic review of the literature. Abstract presented at the 158th Annual Meeting of the American Psychiatric Association, Atlanta, Georgia. Available from http://www.psych.org/public_info/libr_publ/abstracts.cfm accessed 12 May 2006.